Resoconti Eli Lilly and Company BOERSE MUENCHEN

Azioni

LLY0

CA28655A1066

Mercato chiuso - BOERSE MUENCHEN Altri mercati azionari 21:44:01 31/05/2024			Variaz. 5gg	Var. 1 gen.
20,6 ^EUR	-.--%		-.--%	-.--%

30/05	Il Governo danese attua regole di sovvenzione più severe per i farmaci per il diabete	MT
30/05	Il produttore di Wegovy, Novo Nordisk, fa causa a nove centri termali, cliniche e farmacie per i farmaci copiati	RE

Resoconti

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Transcript : Eli Lilly and Company, Q1 2024 Earnings Call, Apr 30, 2024	30/04
Transcript : Eli Lilly and Company Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-06-2024 09:10 AM	06/03
Transcript : Eli Lilly and Company, Q4 2023 Earnings Call, Feb 06, 2024	06/02
Transcript : Eli Lilly and Company Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-09-2024 02:15 PM	09/01
Transcript : Eli Lilly and Company Presents at The 6th Annual Evercore ISI HealthCONx Conference, Nov-28-2023 03:50 PM	28/11
Transcript : Eli Lilly and Company Presents at UBS Biopharma Conference 2023, Nov-08-2023 03:00 PM	08/11
Transcript : Eli Lilly and Company, Q3 2023 Earnings Call, Nov 02, 2023	02/11
Transcript : Eli Lilly and Company Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-11-2023 02:55 PM	11/09/23
Transcript : Eli Lilly and Company, Q2 2023 Earnings Call, Aug 08, 2023	08/08/23
Transcript : Eli Lilly and Company Presents at Alzheimer?s Association International Conference 2023, Jul-17-2023 07:30 PM	17/07/23
Transcript : Eli Lilly and Company Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-12-2023 01:20 PM	12/06/23
Transcript : Eli Lilly and Company Presents at Bank of America Securities 2023 Healthcare Conference, May-10-2023 10:00 AM	10/05/23
Transcript : Eli Lilly and Company, Q1 2023 Earnings Call, Apr 27, 2023	27/04/23
Transcript : Eli Lilly and Company Presents at Cowen 43rd Annual Healthcare Conference, Mar-06-2023 01:30 PM	06/03/23
Transcript : Eli Lilly and Company Presents at SVB Securities Global Biopharma Conference, Feb-16-2023 12:00 PM	16/02/23
Transcript : Eli Lilly and Company Presents at 5th Annual Guggenheim Oncology Days, Feb-09-2023 10:10 AM	09/02/23
Transcript : Eli Lilly and Company, Q4 2022 Earnings Call, Feb 02, 2023	02/02/23
Transcript : Eli Lilly and Company Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-10-2023 03:45 PM	11/01/23
Transcript : Eli Lilly and Company, 2023 Guidance/Update Call, Dec 13, 2022	13/12/22
Transcript : Eli Lilly and Company Presents at 5th Annual Evercore ISI HealthCONx Conference 2022, Nov-30-2022 12:10 PM	30/11/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

In prima pagina

Il CEO di Eli Lilly sulla lotta all'obesità e lo sviluppo di nuovi farmaci

12 marzo 2024 alle 19:47